Purpose
to identify novel macrofilacidal drugs to combat onchocerciasis and lymphatic filariasis, the project will evaluate combination therapies of albendazole and ABBV-4083 in regard to different treatment regimens, which are essential for subsequent human clinical studies
Grantee
Division
Global Health
Date
APRIL 2019
Region served
GLOBAL
Committed amount
$56,776
Grant topic
Discovery and Translational Sciences
Duration (months)
9
Grantee location
Bonn, Germany
Related work
More about our financials
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.